A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and antiviral activity of
ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267; ABT-450 also known as paritaprevir; ABT-267
also known as ombitasvir) and ABT-333 (also known as dasabuvir) with and without ribavirin
(RBV) in patients with chronic hepatitis C virus genotype 1b (HCV GT1b) infection without
cirrhosis.